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Recent studies (1, 2) have demonstrated a genetic linkage between the HL-A
system of the major histocompatibility complex (MHC)' and deficiency of the
second component of complement (C2). In the first case studied (1) the
propositus who was homozygous for C2 deficiency also was homozygous for the
HL-A haplotype 10,W18. The latter subsequently has been encountered in
association with C2 deficiency in three additional families (2, 3), an extraordi-
nary incidence as compared to that in the general population. In addition,
however, several other HL-A haplotypes have been encountered. The present
studies were carried out to document these relationships further with particular
emphasis on studies with mixed lymphocyte culture (MLC) reactions to
determine the MLC genes involved and to map the location of the C2 gene in
relation to the MHC.
Methods and Materials
Serum samples were obtained from clotted blood, quickly forzen, and stored at -60°C. Samples
were thawed once. C2 determinations for members of the C and G families were performed by radial
immunodiffusion. In addition, the C2 level of the propositus from family C was also measured by
hemolytic titration (4). Theheterozygous individuals were recognized by their levelof C2 which was
closeto one-half of the normal . The levels of C2 in members of the S and K families were reported
previously (1, 2).
HL-A typing was done either by a two-stage microcytotoxicity assay procedure (1) or a one-stage
assay method (2). Unidirectional mixedleukocyte cultures were performed by two methods. Method
A is a slight modification of the procedure described by Hartzman et al. (5). Briefly, lymphocytes
were isolated by Ficoll-Hypaque gradient centrifugation . 1.5 x 10' X-irradiated (3,000 rad)
stimulating and 1.5 x 10' responding cells in a total vol of 0.2 ml of RPMI 1640 medium
supplemented with streptomycin, penicillin, and 20% heat-inactivated normal human serum were
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AI-11843-02, NCI-CA 17404-01, and NCI 08748-10; and RR-102 from the National Institutes of
Health.
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response; SR, stimulation ratio.
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mixed in the wells of Falcon microtiter plates (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.).
Each culture was set up in triplicate. After 6 days of incubation at 37°C in 5% CO, humidified
atmosphere, 2 jCi of ['H]thymidine was added to each culture 16 h before harvesting. The
lymphocytes were harvestedand processed for liquid scintillation counting. Method B is a procedure
reported by Jbrgensen and Lamm (6). Briefly, lymphocytes were isolated by Lymphoprep (Nyegard,
Oslo) gradient centrifugation ; 5 x 10' responding lymphocytes and 5 x 10'stimulating lymphocytes
were cultured in a final vol of 150 Al in RPMI 1640 medium supplemented with bicarbonate, Hepes
buffer, streptomycin, penicillin, heparin, glutamine, and 15% pooled, normal human serum. The
stimulating lymphocytes were X-inactivated by 1,250 rad total irradiation (125 rads per minute). The
cultures were performed in plastic microtiter plates (no. 1-221-24-1, Cooke Laboratory Products,
Alexandria, Va.) and were set up in triplicates . After 120 h of incubation at 37°C in 5% CO,
humidified atmosphere, the cultures were labeled with 0.025,uCi of [2-"C] thymidine in 25 jul RPMI
1640 ([2-"C ]thymidine, spec act 50 mCi/mmol, NewEngland Nuclear, Boston, Mass.). After 24 h of
additional culture, the lymphocytes were harvested on Whatman glass filter paper GF/C and
processed for liquid scintillation counting.
Results of MLC testing are expressed as the mean of triplicate cultures in counts per minute
(cpm). Stimulation ratios (SR) arecalculated from theformulaSR(A) = ABx/AAx. Relative response
(RR) is calculated from the formula RR(A) - (ABx - AAx)/(Reference Response - AAx), where
Reference Response is the response of A against an unrelated normal control or control pool (7).
Application of lymphocyte-defined (LD) homozygous test cells (LD typing cells) as stimulating cells
in the MLC test to define LD specificities demonstrate that the responses obtained fall into two
distinct groups: (a) Individuals who do not carrythe LD specificity definedby theLD typing cell:RR
36% - >100% and (b) Individuals carrying the LD specificity defined by the LD typing cell: RR
0-35%. This last group can be subdivided into a group expressing relative MLC identity: RR 0-10%
and another group defining "LD-likeliness" with RR 11-35%.
SD and LD Homozygous Test Cells.
￿
12 LD homozygous test cellswere included in the study. The
panel of typing cells represent MLC determinants with a cumulated gene frequencyof 0.718. Thetest
cells included the common LD specificities LD-7a, LD-8a, LD-W5a, LD-12a, LD-W15a which are in
genetic linkage disequilibrium with the FOUR locusserologically defined antigens HL-A 7, 8, W5, 12,
and W15. 2 The LD-7a homozygous test cell (CM) is HL-A 3,7 homozygous, and mutually
nonresponsive in MLC test with the original LD-7a test cells (Histocompatibility Workshop,
Copenhagen, 1975, no. 12003) (8). The LD-7a gene frequency in the North American Caucasian
population is 0.11. Thesame LD specificity has a gene frequencyof0.10 in theDutch population (9)
and 0.096 in the Danish population (10). The LD-7a determinant is in genetic linkage disequilibrium
with the FOUR locus antigen HL-A7 (11), the A-value being 0.036 (10) and 0.077 (9).
Results
Families with C2 Deficiency.
￿
The S family was the first family wherestudies
showed the linkage between HL-A histocompatibility genes and those involved in
the synthesis of C2 (1). A part of the S family is shown in Fig. 1 a. The propositus,
L. S. is homozygous for C2 deficiency and the HL-A 10,W18. Similar linkage was
also found in the large K family (2). In Fig. 1 b, a part of the K family is depicted.
The propositus, R. K., is homozygous for C2 deficiency but heterozygous for the
HL-A haplotypes 2,4A2* and 10,W18. After these initial studies, two additional
Caucasian families, C and G, have recently been encountered at The Rockefeller
University, New York. Their pedigrees are depicted in Fig. 2. The propositus, J.
C. in family C, is a woman with discoid lupus erythematosus who is homozygous
for C2 deficiency . Clinical details of this case will be reported elsewhere (4). The
propositus is heterozygous for the HL-A haplotypes 9,5 anf10,W18 . Sheobtained
2 Hansen J. A., B. Dupont, L. Slater, R. A. Good, C. Jersild, M. Fotino, P. Rubinstein, F. Allen, N.
Suiciu-Foca, E. Mickelson, D. L. Thomas, S. M. Fu, and H. G. Kunkel. 1975. VI International
Histocompatibility Workshop, 1975. In preparation .0.
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FIG. 1.
￿
Parts of pedigrees of (a)Family S and (b) Family K. The heterozygous and
homozygous C2-deficient cases are indicated by the solid black symbols andthe HL-A type is
given in adjacent space.
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FIG. 2.
￿
(a) The pedigree of Family C and (b) the pedigree of Family G. Theheterozygous and
homozygous C2-deficient cases are indicated by the solid black symbols and the HL-A type is
given in adjoining space. The HL-A assignment for I, andIZ in Family C were made from the
typing results of their family members and are indicated by double asterisks.
the HL-A haplotype 10,W18 from her mother . The father is unavailable for
typing. There is no history of consanguinity. The propositus in the G family is
healthy and heterozygous for C2 deficiency. Her father and her son are also
heterozygous for C2 deficiency. In this family, the gene for C2 deficiency appears
to be linked to the HL-A haplotype 10,W18 .
Identical MLC Locus Associated with C2 Deficiency.
￿
As reported previously
(1) the propositus, L. S. of the S family, is homozygous for the MLC (LD) locus.
A part ofthe S family pedigree relevant to this discussion is shown in Fig. 1 a and
the MLC homozygosity of L. S. is documented in Table I. L. S. failed to498
Responding cells:
HL-A genotypes
* MLC reactions were carried out according to Method A.
$ See Table I.
§ Indicates homozygous C2 deficiency.
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stimulate the cells of her children G. S. and C. D., while here childrens' cells
stimulated her cells well.
Although the propositus, J. C., in the C family, is heterozygous for the loci of
the HL-A system, she is homozygous for the MLC locus as shown in Table II .
None of her three children responded to her cells while she responded to their
cells. MLC homozygosity of J. C. is also shown in the MLC reactions between her
children, K. C. and M. C. Both K. C. and M. C. inherited the same HL-A
haplotype 3,7 from their father, F. C. Although they inherited different HL-A
haplotypes from their mother, J. C., they were nonreactive in MLC. This
indicates that identical MLC determinants are associated with the HL-A
haplotypes 9,5 and 10,W18. In addition, J. C. (from the family C) and L. S. from
the family S were mutually nonreactive in MLC.
In the family K(2), the propositus R. K., as shown in Fig. 1 b, is heterozygous
for the HL-A loci. In Table III is shown the results of MLC testing performed
TABLE I
MLC* Reactions Among Members of the S Family Showing the Propositus, L. S., to be
Homozygous
Stimulator cells
L. S. x
￿
A. S. x
￿
G. S . x
￿
C.D .x
* MLC reactions were carried out by Method A .
$ cpm indicates the means of cpm of triplicate samples.
§ SR is the stimulation ratios (ABx/AAx) and is expressed as the nearest integer.
11 Indicates homozygous C2 deficiency.
TABLE II
MLC* Reactions Among Members of the C Family and L. S. Showing J. C., the Propositus,
Homozygous and MLC Identical to L.S.
Stimulator cells
Respondingcells:
HL-A genotypes L.S.x
cpm$ SR§
J. C.
cpm
x
SR
F. C.
cpm
x
SR
K. C.
cpm
x
SR
S. C.
cpm
x
SR
M.C.X.
cpm SR
L. S.§: 10,W18/10,W18 (1,039) - 1,259 1 21,588 21 17,184 17 8,188 8 4,782 5
J. C.§ (mother): 9,5/10,W18 1,065 2 (689) - 25,131 36 16,556 24 19,302 28 15,139 22
F. C. (father): 3,7/2,W22 26,614 67 29,760 75 (397) - 31,981 81 31,494 79 23,972 60
K. C. (child) : 3,7/10,W18 1,514 3 1,941 3 23,972 40 (602) - 30,240 50 1,077 2
S. C. (child): 2,W22/9,5 1,159 2 946 1 15,909 22 20,064 28 (714) - 18,780 26
M. C. (child): 3,7/9,5 1,671 2 629 1 33,254 47 3,955 6 54,872 78 (702) -
cpm$ SR§ cpm SR cpm SR cpm SR
L. S.1I, (mother) : 10,W18/10,W18 (238) - 10,834 45 25,343 108 9,575 40
A. S., (father) : 11,12/3,5 5,491 11 (485) - 47,229 97 24,606 50
G. S ., (child): 3,5/10,W18 1,351 1 64,090 33 (1,922) - 75,835 39
C. D., (child): 11,12/10,W18 2,660 2 61,673 41 71,423 48 (1,501) -a
cDL--p0~ I O M M Nd'cD
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TABLE V
MLC* Reactions of C2-Deficient Homozygotes
* MLC reactions were done by Method B.
$ See TAble III.
§ "Pool" indicates a pool of cells from four unrelated individuals.
11 Indicates homozygous C2 deficiency.
$ Un indicates unknown LD genotypes which are not 7a.
Stimulator cells
between the family members of family K and the C2-deficient patient L. S.
(family S) . The lymphocytes of L. S. and of the propositus R. K. (family K) are
mutually nonresponsive in MLC tests. L. S. and R. K. do not stimulate the
lymphocytes from family members in family K with the HL-A haplotypes 2,4A2*
and 10,W18. These family members are also heterozygous for C2 deficiency . The
C2 normal family member Rh . K., who has inherited the other two parental
HL-A haplotypes 2,13 and 2,W27, shows a normal MLC response when
stimulated by the cells of L. S. and R. K. Proofof the LD homozygosity of the R.
K. cells is given by the MLC combinations Ro. K. x Ri. K. (2,4A2*/2,13 x
10,W18/2,13) and by the combinations L. K. x Ri. K. (10,W18/2,W27 x
2,4A2*/2,W27) .
In the other C2-deficient family, i.e. family G, the propositus is heterozygous
for HL-A loci and C2 deficiency . The members of the G family stimulated L. S.
cells well (Table IV). However, those with the HL-A haplotype 10,W18 (A . G., M.
G., and P. G.) failed to respond to L. S. in the MLC reaction while the otherthree
members of the family responded well.
Thus, it appears that the three C2-deficient homozygous individuals from
different families are mutually nonreactive in MLC and the C2-deficient
heterozygotes did not respond to the cells of the C2-deficient homozygotes. This
point is further documented in a separate experiment shown in Table V. Here it
is shown that the MLC gene associated with the C2 deficiency gene is LD-7a. In
this experiment, values for the responses were calculated as RR. The cells from
the three C2-deficient homozygotes and a known LD-7a homozygote, CM
without C2 deficiency, were mutually nonreactive. In this testing lymphocytes
from three known LD-7a heterozygous individuals with normal C2 levels (M . T.,
T. K., and E. S.) were included. The lymphocytes from the three homozygous
C2-deficient patients (L . S., R. K., and J. C.) functioned as LD homozygous test
cells when stimulating the LD-7a heterozygous cells, and the mutual MLC
identity between the three cells and the LD-7a homozygous test cell (CM)
identified the LD-7a determinant as the appropriate LD specificity. The three C2
homozygous cells did not show typing responses with LD homozygous test cells
Responding cells
HL-A genotypes LD-genotype
C.
cpm$
M. x
SR$ RR$
L.
cpm
S. x
SR RR
R.
cpm
K. x
SR RR
C. M.: 3,7/3,7 7a/7a (212) - - 1,656 7.8 13 2,346 11.1 20
L. S.11 : 10,W18/10.W18 314 2.3 2 (134) - - 707 5.3 7
R. K.11 : 2,4A2*/10,W18 1,172 9.3 14 823 6.5 9 (126) -
J. C.11 : 9,5/10,W18 471 4.7 4 375 3.8 3 170 1.7 0
M. T.: 9,7/1,TY 7a/UnT 2,404 4.6 19 4,369 8.8 41 1,840 3.5 13
T. K.: 3,7/1,8 7a/8a 937 2.1 4 3,546 8.0 27 3,792 8.6 29
E.S.:1,2,W5,W18 7a/Un 628 3.1 4 1,696 8.5 15 802 4.0 6
B. D.: 2,10,5,MK Un/Un 8,398 23.2 84 4,459 12.3 42 4,438 12.3 42FU ET AL .
(L. S., R. K., J. C.) and 7a and non 7a Individuals
Stimulator cells
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other than the I D-7a. The relative response of 41% by the LD-7a heterozygous
cells from M. T. when they were stimulated by the L.S. cells, was the only dis-
cordant observation. The L. S. cells have been included as an L. D. homozygous
test cell to stimulate a panel of randomly selected normal Caucasian blood donors
in New York City. Of 42 individuals tested so far, seven showed typing responses
to the test cells, giving a gene frequency of 0.087 . This is a slightly lower gene
frequency than the one for the LD-7a test cell (0.110). The studies seem to indi-
cate that the L. S. test cell may express minor LD inclusions on the major LD
locus in addition to the LD-7a specificity (12).
Cross-over Between the HL-A Loci and the C2 Gene.
￿
HL-A and LD typing of
the family members in family C (Fig. 2 a) together with C2 level determinations
seem to supply additional information concerning the mapping of the C2 gene in
relation to the MHC. The mother (J. E.) of patient J. C. is C2 heterozygous . Her
two siblings H. B. (10,W18/1,W17) and W. L. (W19,W18/1,W17) have normal C2
levels. They are mutually nonreactive in MLC testing and do not carry the LD-7a
determinant as shown by the vigorous response to the LD-7a test cell (CM) and
to the lymphocytes from the two C2 homozygous deficient patients L. S. and J.
C. (Table VI).
Their sister J. E., who has the HL-A haplotype 10,W18 in common with H. B.,
does carry the LD-7a determinant on one haplotype. The positive MLC response
of the LD-7a test cell (CM) to her lymphocytes demonstrate, however, that J. E.
is LD-7a heterozygous. Her diseased child J. C. does not respond to the
stimulation of the maternal cells. The observation that the twosiblings H. B. and
W. L. are mutually nonresponsive in MLC, together with the above observation,
indicates that the two MHC haplotypes 10,W18 and W19,W18 must have some
LD components in common but differ on others . Thus, H. B. might represent a
recombinant, but less likely possibilities could be considered.
Discussion
Four C2-deficient families from different geographic locations andwith diverse
national origins were studied in this investigation. The proposita from three
J.
cpm
C. x
SR RR
M.
cpm
T. x
SR RR
T.
cpm
K. x
SR RR
B.
cpm
D.
SR RR
Pool§ x
cpm SR RR
639 3.0 4 9,894 46.7 92 5,842 27.6 53 8,187 38.6 76 10,665 50.3 100
259 1.9 1 6,275 46.8 81 2,006 15.0 24 7,246 54.1 94 7,690 57.4 100
322 2.6 2 4,745 37.7 99 3,160 25.1 41 5,391 42.8 71 7,466 59.3 100
(100) - - 6,918 69.2 84 4,187 41.9 50 6,845 68.5 83 8,165 81 .7 100
2,808 5.4 23 (519) - - 5,280 10.2 48 9,471 18.2 91 10,295 19.8 100
2,308 5.2 16 11,951 27.0 102 (442) - - 12,827 29.0 110 11,694 26.5 100
1,351 6.8 12 8,211 41.0 82 6,900 34.5 69 9,410 47.0 95 9,895 49.5 100
6,125 16.9 60 10,236 28.3 103 10,974 30.3 111 (362 - - 10,155 28.1 100502
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families are homozygous for C2 deficiency and those of the fourth family are
heterozygous for C2 deficiency. HL-A typing studies ofthese families reveal that
the haplotype 10,W18 is encountered in all four individuals. Since one of them
(L. S.) is homozygous for the HL-A haplotype 10,W18, this haplotype is present
in five instances. Other HL-A haplotypes encountered in these families associ-
ated with C2 deficiency are HL-A 9,5, HL-A 2,4A2*, and HL-A2, W18 (1-3). The
haplotype HL-A 10,W18 has a gene frequency of less than 1% (13). The
prominence of this haplotype in association with C2 deficiency appears to
represent a remarkable linkage disequilibrium between these two loci. The more
accurate estimate of this phenomenon will be available as more C2-deficient
families are being typed for HL-A antigens.
Family studies in MLC reactions indicate that the MLC locus is even more
closely linked to the genes of C2 deficiency. Particularly striking was the finding
that the three C2-deficient homozygotes of the three families were mutually
nonreactive in the MLC reactions. In addition, the heterozygous C2-deficient
individuals in the fourth family were nonreactive to the stimulation by the one of
these homozygotes tested. Thus, these data indicate that the seven MHC
involved in the C2 deficiency of the four families possess an apparently identical
MLC gene. Further MLC typing experiments revealed that LD-7a is involved in
all these instances. LD-7a is relatively common in the Caucasian population with
a gene frequency of 0.11 in the North American Caucasian population and is in
positive genetic linkage disequilibrium with the FOUR locus antigen HL-A7
(9-11) . The exact gene frequency ofC2 deficiency in the Caucasian population is
not known but it is reasonable to assign an estimate of 0.01-0.02 (14). Thus, the
association of LD-7a with C2 deficiency also appears to show linkage disequilib-
rium. More family studies are needed to determine ifother LD determinants are
involved in C2 deficiency.
The association of LD-7a with C2 deficiency in these families deserves further
comment. This MLC determinant has been shown to be associated with patients
with multiple sclerosis (15). Furthermore, the patients with multiple sclerosis
have some suppression of cell-mediated immunity (16, 17). The three homozy-
gotes in this study have manifestations of systemic lupus erythematosus (SLE).
It is relevant that similar suppression of cell-mediated immunity has also been
demonstrated in SLE (17). Perhaps, the associated immune response genes
predispose these homozygotes tohave the lupus erythematosuslike syndrome and
possibly healthy homozygotes with C2 deficiency might possess different immune
response genes. As further studies involving these C2-deficient individuals
progress, a clear answer to this questions should be obtained.
One individual of the C family in these studies might represent a recombinant
within the MLC locus and the C2 gene. She has the HL-A haplotype 10,W18, as-
sociated with C2 deficiency in other members of this family, but she is neither
LD-7a nor a C2-deficient individual. This findingwould place the genes governing
C2 deficiency close to the LD genes which have been placed outside the second
and the first HL-A locus. As reported in previous studies (2), an additional possi-
ble recombinant between the FOUR and C2-deficient loci is found in the Kfam-
ily. Ifthis is indeed the case there are two recombinants resulting from 50 meiotic
events in the four families and the recombination frequency between the FOUR
HL-A locus and that of C2 deficiency is approximately 4%. This frequency is ex-504
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traordinarily high in view of the marked linkage disequilibrium betweenthese two
loci. The reasons for this paradoxical phenomenon are obscure. It is estimated
that the recombination frequency between the FOUR HL-A locus and the major
MLC locus is less than 1% (18) . These very preliminary and indirect estimations
would suggest placing the locus governing C2 deficiency outside the major MLC
locus as well as the HL-A loci. One of the chromosomes encountered in this study
would have the relevant genes in the following order: C2 deficiency, 7a, W18,
HL-A10; the genes of the major histocompatibility complex and C2 deficiency on
chromosome 6 might be assigned the following order: C2 deficiency, MLC
(major), HL-A (FOUR locus), HL-A (LA locus) . Further studies certainly are re-
quired to substantiate these relationships .
In addition to C2 deficiency, the locus for factor B ofthe alternate complement
pathway is closely linked to the HL-A histocompatibility locus (19) . In this case,
the structural gene for factor B is probably involved . Although it is likely that C2
deficiency results from some structural gene alteration involving the C2 gene
itself, the possibility still remains that a regulator or another gene defect in the
synthetic pathway of C2 might be involved . In the mouse, the accumulated
evidence suggests that the S region in the H-2 complex controls complement
activity either directly by containing the strucutral gene for one or more
components or indirectly by a regulatory pathway (20) . Serum C3 levels have
been shown to vary from strain to strain and the gene responsible for this
variation is linked to the H-2 complex (21) . The possibility also exists that the Ss
protein of the mouse determined by the S region is itself a complement
component (22) . Evidence exists that it is not C3 or Factor B. However, the
possibility that it might represent C2 remains open . The positioning of the C2
deficiency gene mentioned above is not directly parallel to the Ss position of the
mouse but there are a number of known differences in this genetic region between
the mouse and human genes (18) .
Summary
Four families with C2 deficiency were studied. Among eight HL-A haplotypes
involved with C2 deficiency, five were HL-A 10,W18 . Three homozygotes for C2
deficiency from different families were mutually nonreactive in mixed lympho-
cyte cultures (MLC) and the heterozygotes from the fourth family failed to react
to the homozygous cells. It appeared that identical MLC determinants were
associated with all the genes from the different families that related to C2
deficiency. Further experiments identified the MLC determinant, LD-7a, as
being involved. Theseresults suggest marked linkagedisequilibrium betweenthe
genes for C2 deficiency and the major histocompatibility complex (MHC).
Studies of possible recombinants have offered tentative evidence for the position-
ing of the locus for C2 deficiency with respect to other segments ofthe MHC.
We acknowledge the excellent technical assistance of Ms. Ruth Brooks, F. Joslin, S. Feuerstein, S.
Jaramillo, P. Onasis, J . Blank, and Mr. C . Craig.
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Note added in proof: Two additional families with C2 deficiency subsequently have been
studied. In one instance the C2 deficiency was not associated with LD-7a. Thus, in a total
of six families, five showed the association.FU ET AL .
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